# Fixed Dose Triple Therapy in Severe Chronic Obstructive Pulmonary Disease in a Real World Setting

> **NCT03627858** · — · COMPLETED · sponsor: **Chiesi SA/NV** · enrollment: 149 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** beclomethasone / formoterol / glycopyrronium

## Key facts

- **NCT ID:** NCT03627858
- **Lead sponsor:** Chiesi SA/NV
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-01
- **Primary completion:** 2020-08-03
- **Final completion:** 2020-08-03
- **Target enrollment:** 149 (ACTUAL)
- **Last updated:** 2021-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03627858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03627858, "Fixed Dose Triple Therapy in Severe Chronic Obstructive Pulmonary Disease in a Real World Setting". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT03627858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*